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Abstract
In their 2017 article, Mannion and Exworthy provide a thoughtful and theory-based analysis of two parallel 
trends in modern healthcare systems and their competing and conflicting logics: standardization and 
customization. This commentary further discusses the challenge of treatment decision-making in times of 
evidence-based medicine (EBM), shared decision-making and personalized medicine. From the perspective of 
systems theory, we propose the concept of individualized standardization as a solution to the problem. According 
to this concept, standardization is conceptualized as a guiding framework leaving room for individualization in 
the patient physician interaction. The theoretical background is the concept of context management according 
to systems theory. Moreover, the comment suggests multidisciplinary teams as a possible solution for the 
integration of standardization and individualization, using the example of multidisciplinary tumor conferences 
and highlighting its limitations. The comment also supports the authors’ statement of the patient as co-producer 
and introduces the idea that the competing logics of standardization and individualization are a matter of 
perspective on macro, meso and micro levels.
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Mannion and Exworthy1 provide a timely discussion on the seemingly contradictory trends towards both the standardization and the customization 
of healthcare and medical treatment. With this paper, the 
authors make an important contribution to an understudied 
topic of health services research. The authors describe and 
define standardization and customization within healthcare 
and discuss the implications of both parallel trends for 
healthcare delivery based on sociological theory. Specifically, 
in analogy to the Greek myth of the Procrustean bed, arbitrary 
standardization is described as forced conformity. 
Customization, Personalization and Individualization – 
What Is the Difference?
In contrast to Mannion and Exworthy, we suggest to 
differentiate the terms customization, personalization 
and individualization in healthcare (see Figure). Whereas 
customization is the tailoring of standardized treatment 
and diagnosis to the psychological, social, and cultural 
dimensions of the patients, eg, patient preferences and wishes, 
personalization in medicine means the adaption of treatment 
to the biological dimensions of the patient’s body. Thus, 
personalization means that “medical care can be tailored to 
the genomic and molecular profile of the individual.”2 The 
term individualization can be used as the umbrella term for 
the adaption of health services to the patient’s biological, 
psychological, social and cultural dimensions.3
Drivers of Individualization
Around 25 years ago, the idea of evidence-based medicine 
(EBM) was spread. Whereas at first providers were skeptical 
of the concept of grounding treatment decisions largely 
on research evidence instead of clinical experience, the 
paradigm of EBM is now widely accepted. EBM facilitated 
standardization in healthcare, eg, by developing and 
implementing clinical practice guidelines. Nowadays, in times 
of personalized medicine, a “one fits all” type of treatment 
has its limits.4 Patient care is increasingly customized or 
personalized as a result of three trends. Firstly, the growing 
scientific knowledge facilitates precision medicine due to 
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highly specific individual diagnostics and tailored therapies.4,5 
Secondly, the increasing number of multimorbid patients urges 
deviation from evidence-based guidelines, since guidelines 
seldom address the co-occurence of two or more diseases.6 
Thirdly, patient empowerment urges shared decision-making 
between provider and patient.7 As a consequence, the use of 
research evidence in treatment decision-making is changing: 
more individualization of medical treatment to individual 
patients is required. In healthcare practice, providers and 
patients face the task to integrate up-to-date knowledge 
and patient preferences in decisions concerning individual 
patients, while under many pressures and constraints from 
the healthcare system.7
Clinical practice guidelines are the prime example for a 
widespread tool for standardization in healthcare. The authors 
address some of the issues regarding the use and usefulness of 
these guidelines in practice,8 and thereby, describe the conflict 
between standardization and individualization. Besides the 
sometimes-insufficient and quickly changing evidence base 
of guidelines and problems with acceptance and adherence 
among providers,9-13 it is important to mention the limitations 
of evidence-based guidelines per se. Guidelines cannot 
encompass evidence-based recommendations for every 
potentially emerging case. Guidelines can only inform 
recommendations for the most common types of cases. For 
specific and complex cases, including multimorbid patients, 
the experience and tacit knowledge14 of the provider (the 
authors call it “mindlines”), as well as the patient’s conditions 
and preferences, must play an even bigger role in decision-
making.7 Whereas standards provide the rules of thumb, 
individualization provides a construct to fill-in the gaps 
in knowledge for specific cases. Thus, standardization 
has its natural limitations, and deviations from guideline 
recommendations for specific cases may be necessary and 
beneficial, as shown in a recent study from Germany.15 In 
these cases, formal sanctioning deviating provider behavior 
will be harmful to providers and patients.3 
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Mannion and Exworthy outline a well-justified need for 
research on the strategies of deciding between, or balancing, 
standardization and individualization in everyday healthcare. 
Nowadays, one of the provider’s main tasks is to break 
down standards to the individual patient and not to force 
conformity. Like the authors stated, medicine is always 
individual opposed to public health focusing on populations. 
But evidence from clinical studies usually is not reported for 
every single subgroup of patients. Within the consultation, 
the provider needs to transfer evidence-based knowledge on 
populations to the individual patient.7 Thus, in the following 
we propose a concept of individualized standardization as a 
solution to the described challenge.
The Concept of Individualized Standardization
Individualized standardization of care “is defined as the 
imposition of standards, regulations or norms which 
are tailored to the genes, body condition, culture, social 
environment, values, needs and preferences of the individual 
patient.”3 Individualized standardization is conceptualized as 
a guiding framework leaving room for individualization in the 
patient-physician interaction system, which can be regarded 
as an autopoetic target group. The term “autopoiesis” was 
shaped by Niklas Luhmann, a German sociologist and co-
founder of systems theory16 and describes the process of 
self-preservation of social systems. A system is autopoetic, 
when it constantly and non-purposefully reproduces itself 
from within itself. Individualization, as described above, 
means taking into account the biological, psychological, 
social and cultural dimensions of the patient, eg, patient 
preferences and wishes. The theoretical background is the 
concept of context management according to systems theory. 
“Context management can be viewed as a technique that 
creates an environment in which an autopoetic target group 
is more sensitive to steering signals. Context management 
is a technique making use of the self-referential closure of 
the autopoetic target group.”17 Transferred to healthcare, 
context management creates an environment in which the 
patient-physician interaction is sensitive to steering signals, 
eg, guideline knowledge, quality management activities, 
expertise from other disciplines and molecular diagnostics. 
Within this context treatment has to be individualized within 
a given framework (ie, standardization). The aim is to merge 
evidence with patient preferences. As Barratt argues,7 this 
ideal aim could only be reached by intensive training. For her 
it is “really important (…) that future doctors are trained to 
individualize treatment to patients – because that is necessary 
for doing a good job of both EBM and SDM [shared decision 
making].” And she adds: “we should not have a view that 
good practice requires doctors – and patients – to follow or 
comply with guidelines.”7 One example for the realization of 
the idea of merging individualization and standardization 
in clinical practice are multidisciplinary tumor conferences 
(MTCs). MTCs can be regarded as autopoetic groups with the 
tendency to self-referential closure.
Individualized Standardization in Multidisciplinary Tumor 
Conferences
One example for the integration of standardization and might 
be multidisciplinary teams in oncology. MTCs have been 
Figure. Conceptual Differentiation Between Individualization, Personalization, 
and Customization in Healthcare.
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established to deal with the complexity of oncological care 
and to support treatment decision-making. MTCs are regular 
meetings of a multidisciplinary treatment team in which 
the diagnosis, prognosis and treatment of cancer patients 
are discussed.18 In MTCs, treatment recommendations are 
not only to be made based on evidence and standardized 
protocols, but also on input and perspectives from multiple 
disciplines on the individual patient. Here, deviations 
from guidelines are possible, but need to be reasonably 
explained. These deviations are in most cases results of 
the individualization of standardized procedures and can 
be beneficial for the individual patient.15 The patients’ 
conditions (eg, comorbidities, social environment) and their 
wishes and preferences should be considered and inform the 
recommendation, as well. Admittedly, the composition of 
disciplines participating in MTC is selective, too. Nurses, who 
commonly have the best knowledge about the patients’ social 
environment and preferences and thus could act as a patient’s 
advocate, seldom take an active part in the MTC.19 For this 
reason, some clinic began to invite patients to take part in their 
own MTC.18 On the one side, studies reveal benefits of MTCs 
for treatment decision-making,20 and MTCs are accepted and 
valued by providers and patients.21,22 On the other side, studies 
show that the patients’ characteristics and perspectives are 
seldom considered in MTCs19,23,24 and recommendations from 
the MTCs are not always followed by patients and providers.23 
In summary, the idea of MTCs is somewhat representative of 
the concept of individualized standardization.3
The Patient as Co-producer
Another natural limitation to standardization in healthcare 
are the patients, themselves. In human services, the client - 
here the patient - needs to cooperate in order to fulfill the 
service. As mentioned by Mannion and Exworthy, the patient 
is a “co-producer.” In healthcare, this is especially relevant, 
since treatment success is strongly dependent on the patient’s 
cooperation, adherence and trust.25-27 Moreover, patients need 
to give their explicit consent to medical procedures. Thus, 
even if the evidence-based standard was recommended to 
the patient, the patient can choose a different treatment, can 
refuse treatment, and does not eg, have to take the prescribed 
medication. And patients can get a second opinion from 
a different provider before deciding, which again ensures 
quality and standards. Furthermore, financial constraints 
of the patients and reimbursement policies for providers 
may play a central role in treatment decision-making, too.28 
Hence, the patients’ behavior in decision-making cannot be 
completely controlled by standardization.29,30 
Personalized Medicine as a Challenge to Shared Decision 
Making and the Healthcare System
The authors describe the trend towards individualization by 
using the example of personalized medicine, which we will 
be confronted with in the future even more, as described 
above. Personalized medicine uses big data, eg, oncological 
databases such as CancerLinQ, Flatiron and IBM Watson, 
in order to identify differentiated patient profiles, which are 
used to decide on highly-targeted and effective therapies.31 
Big data can help to identify promising treatment options 
based on the patient’s biology, but still the patient needs to 
be empowered to understand the options and participate in 
the treatment decision-making. Due to the complexity of 
the options, it will be even more challenging for providers to 
inform and involve patients in treatment decisions. From a 
systems’ perspective, a central question arises: How can we 
regulate personalized medicine in our healthcare systems and 
how can the costs be handled? The need for regulation stems 
from the need to ensure high quality care and prevent harm, 
as well as from the need to restrict utilization of services in 
personalized medicine due to financial constraints of the 
healthcare and insurance systems. In this regard, research 
and policy are urgently required to develop feasible and fair 
solutions. First studies reveal that personalized medicine is 
cost-effective due to limiting the use of eg, targeted drugs to 
patients with a certain well-defined risk profile, for which the 
drugs are highly effective.31
All in all, we suggest that the balance between standardization 
and individualization is a matter of perspective. As the 
authors already point out, both trends play out on the 
macro, meso and micro levels. The macro level’s interests 
(society and healthcare system) in healthcare are concerning 
cost-effectiveness, reducing variation between providers, 
affordability and quality assurance; thus, the system potentially 
favors standardization as a form of regulation and context 
management. On the meso level (healthcare organizations), 
the interests are mostly on high-quality care, competition, 
cost-effectiveness and the use and accumulation of resources. 
Hence, standardization and individualization should best be 
balanced to reach these interests. On a micro level, providers 
and teams may focus on treatment success, patient well-
being, ethical care, competition and autonomy; whereas 
patients’ interests may depend on, for example, their needs 
and preferences, treatment success, side effects and trust. On 
the micro level individualization may be more important than 
standardization, whereas on the macro level standardization 
is key. All in all, the question that still needs to be answered 
on all levels is: How do stakeholders in healthcare balance 
or decide between standardization and individualization 
together with their patients?
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